Alzheimer's research reveals drug that addresses DNA damage and brain inflammation

Scientists at King's College London have discovered that an experimental drug originally developed to treat spinal cord injuries can address multiple key features of Alzheimer's disease, ScienceDaily reported. The treatment targets several damaging effects at once, including DNA damage and inflammation in the brain. [1]

According to ScienceDaily, the drug has already been tested for initial safety in human trials. Because it has completed preliminary safety testing, the experimental treatment could offer a faster path toward therapies that target the underlying roots of Alzheimer's disease. [1]

Alzheimer's disease is a neurodegenerative condition that accounts for 60% to 70% of dementia cases. In molecular biology, DNA repair describes the processes cells use to identify and correct damage to their genetic code, which naturally suffers tens of thousands of lesions daily. [2][3]

As HEROIC BREAKING NEWS reported earlier, scientists have previously focused on reducing brain inflammation through various methods, such as blocking the P2X7 receptor in human brain tissue to accelerate drug repurposing efforts for neurodegenerative conditions. [4]